INTRODUCTION
Burkholderia pseudomallei is the causative agent of melioidosis, a disease which presents with a wide variety of symptoms, often including septic shock and lung disease, ranging from subacute to chronic or acute disease. The disease is endemic in northern Australia and SouthEast Asia with annual incidences varying between 19.6 cases per 100 000 of the population in the Northern Territory of Australia to 4.4 cases per 100 000 of the population in Thailand (Currie et al., 2004; Suputtamongkol et al., 1994) . Due to high mortality rates (around 80 % in individuals with bacteraemia or sepsis) and its potential as a biological weapon, B. pseudomallei is currently classified as a category B select agent by the Centers for Disease Control and Prevention (CDC) (Bossi et al., 2004) . B. pseudomallei is an environmental pathogen, contracted by contact with soil or water through a break in the skin or by inhalation of the aerosolized pathogen. This route of transmission has led to increased melioidosis outbreaks during the rainy season as more people are exposed to the pathogen in aerosol form. The disease is more prevalent in individuals with predisposing conditions such as diabetes mellitus or renal disease, and both disease initiation and outcome of infection with B. pseudomallei are largely dependent on the host immune response. A strong cell-mediated immune response with production of interferon gamma (IFN-c) is known to be important in protection from primary infection in mice (Haque et al., 2006) and is also believed to be important in protecting against human infection (Tippayawat et al., 2009 ).
Dendritic cells (DCs) are present in virtually every tissue of the body and are a first line of defence against invading pathogens. They act as sentinels, sampling foreign antigens that induce their functional maturation and migration to the lymph nodes. Here they activate T cells and tailor the adaptive immune response accordingly. Due to their role in defence they are a common target for immune modulation by a number of pathogens (Fugier-Vivier et al., 1997; Liu et al., 2009; McGuirk et al., 2002; Prechtel et al., 2005; van Kooyk et al., 2003) . They are also a potential mode of transport to the lymph nodes for further dissemination and are often utilized as such by viruses (Pohl et al., 2007) . Additionally, for those pathogens that can survive phagocytosis and antigen processing, such as Mycobacterium tuberculosis and Listeria monocytogenes (Giacomini et al., 2001; Kolb-Mäurer et al., 2000) , DCs can provide a reservoir in which to replicate.
As a facultative intracellular pathogen, B. pseudomallei can replicate in a number of phagocytic and non-phagocytic cells lines (Jones et al., 1996) , including macrophages, which share a common lineage with DCs. The related pathogen, Burkholderia cenocepacia disrupts DC maturation and induces necrosis after uptake of live bacteria (MacDonald & Speert, 2008) . It therefore seems plausible that B. pseudomallei should also belong to the growing list of pathogens that elicit an abnormal immune response from DCs. Using a mouse model, it has been shown that B. pseudomallei is cleared by murine bone-marrow-derived dendritic cells (BMDDCs) and that DC maturation is induced, regardless of strain virulence (Williams et al., 2008) . In human studies, the maturation of monocytederived dendritic cells (MDDCs) in response to B. pseudomallei has been demonstrated (Charoensap et al., 2008) . In contrast to the mouse study, it was also reported that both B. pseudomallei and B. thailandensis survive and replicate within human DCs and stimulate their maturation as measured by surface marker expression (Charoensap et al., 2009) .
The aim of this study was to assess the survival of a panel of B. pseudomallei strains as well as that of the relatively avirulent, but related, bacterium B. thailandensis (Brett et al., 1998) in human MDDCs, and to examine the effect of infection on cytokine secretion.
METHODS
Bacterial strains and culture. Details of the bacterial strains used in this study are given in Table 1 . Bacteria were grown overnight at 37 uC for 16 h, either on LB agar or in LB broth shaken at 200 r.p.m., prior to use. Antibiotics were added when appropriate.
Generation of DCs from peripheral blood mononuclear cells (PBMCs). MDDCs were generated using standard protocols (Sallusto & Lanzavecchia, 1994) . Whole blood was obtained by venipuncture, with informed consent, from healthy adult volunteers aged 18-50. This study was approved by the Griffith University Human Ethics Committee. PBMCs were isolated from heparinized whole blood by density-gradient centrifugation using the ficoll-hypaque technique (Bio-Lynx, Gibco). Cells were seeded into six-well plates (Gibco) at concentrations of~4610 6 cells per well and incubated for 1 h at 37 uC and washed with PBS to remove non-adherent cells. Complete RPMI medium, minus antibiotics, containing 10 % (v/v) heat-inactivated fetal calf serum (FCS; Gibco) and supplemented with 100 ng ml 21 IL-4 and 100 ng ml 21 GM-CSF (PeproTech) was added to the remaining monolayers. After 7 days of incubation, including one complete replacement of media, at 37 uC in a 5 % CO 2 atmosphere, cells were removed from plates by gentle scraping and cells with an immature DC phenotype were confirmed by flow cytometry as detailed below. In concordance with other studies, cells were .95 % pure (MacDonald & Speert, 2008; Noske et al., 2009 ).
Flow cytometry. MDDCs suspended in PBS at a concentration of 10 6 cells per tube were incubated with combinations of fluorochrome-conjugated antibodies (lineage cocktail 1: FITC CD3, CD14, CD16, CD20, CD56; PE mouse anti-human CD1a; PE mouse antihuman CD86; PeCy5 mouse anti-human CD206; and FITC mouse anti-human CD80). All antibodies were acquired from BD unless otherwise stated. After 30 min of incubation at 4 uC in the dark, the cells were washed twice in PBS and 2 % (v/v) FCS and resuspended in 1 % (v/v) paraformaldehyde (Sigma). Samples were analysed using a Facscalibur flow cytometer (BD). As there is no single DC-specific marker (Huang et al., 1999) , the immature DC phenotype was confirmed by the absence of CD3, CD14, CD19, CD56, CD80 and CD86 and the presence of CD1a and CD206. Immature MDCCs were used in infection assays.
Infection assays. MDDCs were grown in RPMI medium with Lglutamine (Gibco) supplemented with 10 % heat-inactivated FCS (Gibco) at 37 uC in 5 % CO 2 . The cells were seeded at a concentration of 1610 4 cells per well into 96-well cell culture plates 24 h prior to infection. Cells were infected with bacteria grown for 16 h (stationary phase) at a multiplicity of infection (MOI) ratio of 1, 10, 50 or 100 bacteria per cell and incubated at 37 uC in 5 % CO 2 for 1 h. Where inactivated bacteria were used, bacteria were heat-killed at 65 uC for 30 min. The culture medium was then removed and replaced with medium containing 10 mg ml 21 imipenem (Sigma) in order to prevent any further extracellular bacterial replication. Incubation was continued for up to 12 h, depending on experimental design. After the infection assays, infected MDDCs were washed and permeabilized using 0.1 % Triton X-100. The released cell-associated bacteria were plated onto LB agar for overnight incubation. Colonies were counted and used to estimate the number of intracellular bacteria. Due to the nature of the assay, with cells lysed in order to provide colony counts, internalized bacteria could not be counted for the same well at different time points; therefore, duplicate wells were used.
All strains used were equally susceptible to imipenem and were unable to grow at concentrations of 1 mg imipenem ml 21 and above (data (1997) not shown). Prolonged effectiveness of imipenem during infection assays was also tested by supernatant sampling of infection assays, conducted in a 24-well plate format. At 6 h post-infection the mean c.f.u. per well present in the supernatant was ,0.07 % of the number of bacteria in the initial inoculum; this value rose slightly to 0.21 % at 12 h post-infection. In parallel experiments, the effectiveness of imipenem, .99.5 % killing, equalled that seen with 250 mg kanamycin ml 21 (data not shown).
Quantification of cytokine production. Cytokine production by MDDCs was measured from infection assay supernatants, which were collected at various time points and stored at 280 uC until use. IL-6, IL-10, IL-12p70 and TNF were measured using OptEIA ELISA kits (BD) according to the manufacturer's instructions.
Statistics. All data analyses were carried out using Prism version 5.0 (GraphPad Software). Cytokine data were log-transformed to improve the normality of the data and expressed as mean±SEM. Bacterial counts were expressed as geometric mean and 95 % CI unless otherwise stated. Statistical differences between multiple groups were assessed using the Kruskal-Wallis one-way ANOVA, followed by Dunn's post test. Statistical differences between two groups were assessed using unpaired t-tests.
RESULTS

Association of B. pseudomallei MSHR520 with MDDCs
The ability of B. pseudomallei MSHR520 to survive and replicate in MDDCs was assessed at 2, 4 and 12 h postinfection by counting viable bacteria from lysed cells. The results show that in this system, B. pseudomallei failed to replicate in dendritic cells. The number of viable intracellular bacteria declined from a geometric mean of 843 c.f.u. per well at 2 h post-infection to 15 c.f.u. per well at 12 h post-infection (P,0.0001, 2 h-4 h; P.0.05, 4 h-12 h; P,0.05, 2 h-12 h) (Fig. 1a) . At 12 h post-infection, there was variation in the numbers of recovered bacteria: in 13/62 wells, the MDDCs had completely eradicated all bacteria, whereas occasional wells exhibited marked bacterial replication (up to 2.6610 6 viable bacteria per well). It may be of note that relatively few internalized bacteria were found, even at 2 h post-infection, reflecting inefficient uptake by MDDCs, which is in accordance with existing MDDC studies (Charoensap et al., 2009) . Additionally, monocyte uptake of B. pseudomallei is reported to be low (Pruksachartvuthi et al., 1990 ) so this observation is not surprising.
A previous study indicated that both B. thailandensis strain UE5 and B. pseudomallei strain 844 could replicate in human MDDCs (Charoensap et al., 2009) . We investigated whether strain differences could account for the apparent discrepancy between our findings and this study (Charoensap et al., 2009 ). In addition, we assessed the capacity of an acapsular mutant (MSHR520Dcap) to survive in MDDCs (Fig. 1b) . No significant differences in mean number of recovered bacteria were seen between strains at this time point (P.0.05). As with B. pseudomallei strain MSHR520, the ability of MDDCs to consistently eradicate bacteria by 12 h post-infection varied between wells and significant replication of all strains was seen occasionally in some wells (Fig. 1b) .
Effect of MOI on internalization and survival of Burkholderia species in DCs
We investigated whether increasing the starting inoculum could lead to a more consistent number of intracellular bacteria at 12 h post-infection. However, no statistical difference in numbers of intracellular bacteria at 4 h was seen between inoculum sizes (P.0.05) when using B. pseudomallei strains MSHR520, K96243 and 576a, and B. thailandensis strain E264 T (Fig. 1c) . This suggests that the uptake mechanism may have a limiting factor and may become saturated by the numbers of bacteria in the initial inocula; therefore, increasing the numbers of bacteria in the inoculum ten-fold would have no effect on intracellular bacterial numbers.
We also investigated the uptake (measured at 2 h postinfection) and survival (measured at 12 h post-infection) of B. pseudomallei MSHR520 at an MOI ratio of 1 : 1 (Fig.  1d) . Our data showed a decrease in intracellular bacteria between 2 and 12 h (P50.0015), similar to that seen in our model with a higher MOI. We did not see significantly increased internalization and survival of B. pseudomallei by MDDCs at this MOI by the 12 h time point (P50.7571), supporting our choice of 10 : 1 as the optimal MOI for bacterial uptake.
Effect of Burkholderia infection on DC cytokine production profile
DCs secrete large amounts of cytokines in response to intracellular infection (Banchereau et al., 2000) . We assessed whether there were any differences in the induction of cytokines in response to different strains. MDDCs were co-incubated for 12 h with live and heatkilled B. thailandensis or B. pseudomallei MSHR520, live unencapsulated B. pseudomallei or one of five other B. pseudomallei strains at an MOI ratio of 10 : 1. Exposure of MDDCs to either live or heat-killed B. pseudomallei or to B. thailandensis induced significant secretion of IL-6, IL-12 and TNF when compared with uninfected cells (P,0.05) (Fig. 2) . While secretion of IL-10 appeared to be increased in exposed MDDCs, these data were not statistically significant (P.0.05). No significant difference was seen in secretion of any of the measured cytokines between MDDCs stimulated with different B. pseudomallei strains, or between cells stimulated with live or heat-killed bacteria (P.0.05) (Fig. 2) . These data indicate that, in our system, activation of MDDCs, measured by cytokine secretion, was not dependent on the presence of live organisms and that activation can be stimulated just as efficiently by dead organisms. Activation of MDDCs at 12 h post-infection was also confirmed by flow cytometry to measure expression of maturation markers CD80 and CD86 (.90 %, data not shown).
No decrease in viability of infected versus uninfected cells, was seen throughout the course of the infection assays as assessed by trypan blue staining and both light and immunofluorescent microscopy (data not shown).
DISCUSSION
Studies on infection of phagocytic cells have mainly utilized mouse cell lines, although recently there have been a number of studies concerning the immune response of human patients, in particular the involvement of cytokines in sepsis (Wiersinga et al., 2009 (Wiersinga et al., , 2010 . Since the outcome of infection is known to be dependent on the human immune response it is possible that B. pseudomallei strains may abrogate the immune response. In addition, whilst B. thailandensis may be comparatively avirulent for a number of reasons, a more effective immune response against this bacterium is also a possibility, leading to decreased symptoms and efficient clearance of the infection.
In the present study we examined the capacity of a number of strains of B. pseudomallei to replicate in human MDDCs. We noted no differences in the numbers of viable intracellular bacteria 12 h post-infection between strains. The most striking finding was that while human MDDCs consistently eliminated or reduced viable bacterial numbers over the course of the infection in the great majority of infected wells, sporadic wells exhibited significant bacterial growth. This variation was not due to differences in the responses of different donor cells as it was also seen between replicates using MDDCs from the same donors. This points to an event between 2 and 4 h post-infection that either results in the complete abrogation of B. pseudomallei infection or allows the infecting bacteria to replicate to a point at which the cells can no longer control the infection. Whilst the nature of such an event and the 'tipping point' are not known, it is likely to be a host factor; further investigation is therefore warranted, which may benefit from microarray studies to compare those cells which permit replication and those which control the infection.
The present study, in which MDDCs are capable of completely clearing bacteria or significantly decreasing viable bacterial numbers within 12 h in the majority of infections, is, for the most part, in agreement with a previous study, in which murine BMDDCs cleared infection by two different strains (B. pseudomallei NCTC 13178 and NCTC 13179) to negligible levels by 18 h postinfection (Williams et al., 2008) . However, the findings of the present study are in contrast with those of another study which reported the capacity of B. pseudomallei strain 844 and B. thailandensis strain UE5 to survive and replicate in human MDDCs but not in macrophages (Charoensap et al., 2009) . These authors used a lower concentration of cells in their inoculum than our study and it has been reported that for a related pathogen, B. mallei, when macrophages were infected with 10 bacteria per cell, the infection was cleared efficiently, whereas a ratio of ,1 bacterium per cell was permissive for bacterial survival and replication (Brett et al., 2008) . Conversely, Williams et al.
(2008) did not see survival and replication in their murine model when using a lower concentration of cells in the inoculum. Therefore, to address this parameter, we used a lower inoculum MOI ratio (1 : 1) in the present study and did not observe increased survival or replication (Fig. 1d) .
One difference between our study and those of Charoensap et al. (2009) and Williams et al. (2008) is the use of imipenem as the antibiotic of choice to control extracellular replication, rather than the aminoglycoside antibiotic, kanamycin; however, we conclude that this variation does not explain the discordance between our studies. Our use of the b-lactam, imipenem, is derived from reports in the literature that suggest that kanamycin is able to penetrate eukaryotic cells and may interfere with either host cell function or even intracellular bacterial replication, a situation that is potentially exacerbated by the high levels of kanamycin required to inhibit growth of B. pseudomallei (Menashe et al., 2008) . Meanwhile, imipenem is lipid insoluble and penetrates cells poorly if at all (Menashe et al., 2008; Murdoch & Peterson, 1991; Sahly et al., 2008) . Numerous other studies have used imipenem (Boddey et al., 2007; Brown et al., 2004; MacDonald & Speert, 2008) rather than kanamycin. We have compared the effects of Table 1 . Burkholderia infections of MDDCs were carried out over a period of 12 h, after which the supernatants were collected and production of IL-6, IL-10, IL-12 and TNF were measured. Data represent the mean of at least three separate infection assays with two separate infection wells per experiment. Bars represent SEM.
the two antibiotics on B. pseudomallei infection of RAW cells (a murine macrophage-like cell line), in which B. pseudomallei does survive and replicate. Our study indicates that, up to 12 h post-infection, infection and replication proceed in a similar manner with both antibiotics being similarly effective in eliminating bacterial cells in the extracellular inoculum to ¡0.21 % of the number in the starting inoculum (data not shown).
Acapsular mutants of B. pseudomallei used in animal models are normally attenuated (Reckseidler-Zenteno et al., 2005) . However, we have previously shown that an acapsulate B. pseudomallei mutant is capable of infecting nasal-associated lymphoid tissue and, presumably, DCs also (Owen et al., 2009) . Similarly, acapsulate B. thailandensis is capable of invasion and replication in murine phagocytic cells, albeit with an altered host-cell response (Boddey et al., 2007) , and the capacity of B. thailandensis to induce lung damage, suggested to be mediated, in part, by inflammatory cytokine production, have been reported (West et al., 2008) . In the present study, we assessed whether the presence of capsular polysaccharide affects bacterial survival and found that neither the acapsular mutant of B. pseudomallei nor a strain of B. thailandensis differed from capsulate B. pseudomallei in their interactions with MDDCs. In addition, B. pseudomallei 576a expressed a different LPS O-antigen to most strains, although, despite this, it also exhibited no difference to other strains. These findings suggest that neither the LPS O-antigen type nor the presence/absence of a capsule play a significant role in interactions between B. pseudomallei and human DCs.
A strong IFN-c response is believed to be essential for clearance of B. pseudomallei (Barnes et al., 2004; Haque et al., 2006) . The production of IFN-c is the hallmark of a cellular Th1-type immune response, which is typically mediated by production of IL-12 by DCs (Heufler et al., 1996) . Cytokine production is a measure of DC activation but exposure to certain pathogens alters the balance of cytokine production. Bordetella pertussis, for example, induces DCs to increase secretion of IL-10 and thereby alters polarization of the immune response and induces tolerance (McGuirk et al., 2002) . In addition to IL-10 and IFNc, we also measured levels of the pro-inflammatory cytokines IL-6, which is essential for development of B cells into Ig-secreting plasma cells (Jego et al., 2003) , and TNF, as elevated levels of pro-inflammatory cytokines have been reported in melioidosis patients with poor disease outcomes and can be used to predict mortality rates (Simpson et al., 2000) . Although a trend was apparent, there were no significant correlations between internalized c.f.u. per well and cytokine production, indicating that equivalent responses were detected in wells in which all bacteria had been killed by MDDCs, or in which heat-killed cells had been added, and those with high bacterial growth. These results indicate that, in this model, the induction of these measured cytokines could be attributable to bacterial components present on heat-killed organisms, and that live bacteria are not required for activation.
When assessing whether different strains elicited different responses, we noted no variation in the induction of cytokine secretion by any of the B. pseudomallei strains for any of the cytokines measured. These findings are in accordance with a recent study measuring IL-12p70 and IL-10 secretion by MDDCs, which also showed no variation between B. thailandensis, B. pseudomallei, or bacteria killed by paraformaldehyde treatment (Charoensap et al., 2009 ).
Conclusions
We have demonstrated, using a number of B. pseudomallei strains, that infection of human MDDCs induces the secretion of cytokines independent of bacterial replication and strain pathogenicity. Additionally, in the majority of cases in this study, the primary human cells were able to decrease the number of intracellular bacteria or clear the infection by 12 h post-infection, providing evidence that B. pseudomallei is normally unable to survive or replicate within DCs. This does not preclude the possibility that, in vivo, they may escape DCs after transport to a distal site and thereby use the cells as a method of systemic dissemination.
Further research into occasions where B. pseudomallei has escaped the bactericidal effects of DCs and gone on to replicate freely, and also the role of DCs in B. pseudomallei infection and pathogenesis using a multi-cell or organ culture model would be useful to further elucidate the precise manner in which the human immune system responds to infection.
